Stockreport

BridgeBio granted Perform rating at Oppenheimer on market challenges [Seeking Alpha]

Alnylam Pharmaceuticals, Inc.  (ALNY) 
Last alnylam pharmaceuticals, inc. earnings: 2/6 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.alnylam.com/investor-overview
PDF With the FDA expected to decide on a marketing nod for acoramidis in a heart condition called ATTR amyloidosis with cardiomyopathy (ATTR-CM) by late November, Oppenheim [Read more]